These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
304 related items for PubMed ID: 6662682
1. Replacement of gentamicin by amikacin as a means of decreasing gentamicin resistance of gram-negative rods in a neonatal intensive care unit. Wielunsky E, Drucker M, Cohen T, Reisner SH. Isr J Med Sci; 1983 Nov; 19(11):1006-8. PubMed ID: 6662682 [Abstract] [Full Text] [Related]
2. [Amikacin in the treatment of hospital infections of the urinary tract caused by gram-negative bacilli resistant to gentamicin. Microbiological and clinical aspects]. Romoli E, Di Leonardo F, Giordano G, De Felice M, Cerquetti F, Vonmoos A. Minerva Urol; 1981 Nov; 33(2):85-90. PubMed ID: 7322100 [No Abstract] [Full Text] [Related]
3. An epidemic oc gentamicin/cloxacillin resistant staphylococcal infection in a neonatal unit. Mulhern B, Griffin E. Ir Med J; 1981 Aug; 74(8):228-9. PubMed ID: 7319781 [No Abstract] [Full Text] [Related]
4. Antibiotic resistance patterns during aminoglycoside restriction. Young EJ, Sewell CM, Koza MA, Clarridge JE. Am J Med Sci; 1985 Dec; 290(6):223-7. PubMed ID: 3936358 [Abstract] [Full Text] [Related]
5. Amikacin therapy of gram-negative bacteremia and meningitis. Treatment in diseases due to multiple resistant bacilli. Sklaver AR, Greenman RL, Hoffman TA. Arch Intern Med; 1978 May; 138(5):713-6. PubMed ID: 348135 [Abstract] [Full Text] [Related]
6. Gentamicin resistance among gram-negative bacillary blood isolates in a hospital with long-term use of gentamicin. Mylotte JM. Arch Intern Med; 1987 Sep; 147(9):1642-4. PubMed ID: 3307673 [Abstract] [Full Text] [Related]
7. Colonization with antibiotic-resistant Gram-negative bacilli in the neonatal intensive care unit. Toltzis P. Minerva Pediatr; 2003 Oct; 55(5):385-93. PubMed ID: 14608262 [Abstract] [Full Text] [Related]
8. Progressive increase in antibiotic resistance of gram-negative bacterial isolates. Walter Reed Hospital, 1976 to 1980: specific analysis of gentamicin, tobramycin, and amikacin resistance. Cross AS, Opal S, Kopecko DJ. Arch Intern Med; 1983 Nov; 143(11):2075-80. PubMed ID: 6639227 [Abstract] [Full Text] [Related]
9. Clinical and microbiologic consequences of amikacin use during a 42-month period. Berk SL, Alvarez S, Ortega G, Verghese A, Holtsclaw-Berk SA. Arch Intern Med; 1986 Mar; 146(3):538-41. PubMed ID: 3954526 [Abstract] [Full Text] [Related]
10. Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy. Leonard JM, McGee ZA, Alford RH. Arch Intern Med; 1978 Feb; 138(2):201-5. PubMed ID: 415674 [Abstract] [Full Text] [Related]
11. [Comparative study and time changes in the resistance to gentamycin, tobramycin, sisomicin and amikacin of Gram-negative nosocomial bacterial strains isolated from the urinary tract, in relation to the annual use of the aminoglycosides tested]. Alegente G, Marchi B, Pieri I, Saturni A, Progenie G, Rubino M. Quad Sclavo Diagn; 1983 Sep; 19(3):343-8. PubMed ID: 6677931 [Abstract] [Full Text] [Related]
12. Epidemiology of gram-negative conjunctivitis in neonatal intensive care unit patients. Chen CJ, Starr CE. Am J Ophthalmol; 2008 Jun; 145(6):966-970. PubMed ID: 18378213 [Abstract] [Full Text] [Related]
13. Molecular typing demonstrating transmission of gram-negative rods in a neonatal intensive care unit in the absence of a recognized epidemic. Almuneef MA, Baltimore RS, Farrel PA, Reagan-Cirincione P, Dembry LM. Clin Infect Dis; 2001 Jan 15; 32(2):220-7. PubMed ID: 11170911 [Abstract] [Full Text] [Related]
14. Outbreak of amikacin-resistant Enterobacteriaceae in an intensive care nursery. Cook LN, Davis RS, Stover BH. Pediatrics; 1980 Feb 15; 65(2):264-8. PubMed ID: 6986597 [Abstract] [Full Text] [Related]
15. Antibiotic-resistant organisms in the neonatal intensive care unit. Bizzarro MJ, Gallagher PG. Semin Perinatol; 2007 Feb 15; 31(1):26-32. PubMed ID: 17317424 [Abstract] [Full Text] [Related]
17. Control of emergence of multi-resistant gram-negative bacilli by exclusive use of amikacin. Ruiz-Palacios GM, Ponce de Leon S, Sifuentes J, Ponce de Leon S, Calva JJ, Huazano F, Ontiveros C, Ojeda F, Bobadilla M. Am J Med; 1986 Jun 30; 80(6B):71-5. PubMed ID: 3089006 [Abstract] [Full Text] [Related]
19. Controlled comparison of amikacin and gentamicin. Smith CR, Baughman KL, Edwards CQ, Rogers JF, Lietman PS. N Engl J Med; 1977 Feb 17; 296(7):349-53. PubMed ID: 319355 [Abstract] [Full Text] [Related]
20. Amikacin: in vitro bacteriological studies, levels in human serum, lung and heart tissue, and clinical results. Faragó E, Kiss J, Gömöry A, Aranyosi J, Juhász I, Mihóczy L. Int J Clin Pharmacol Biopharm; 1979 Nov 17; 17(11):421-8. PubMed ID: 511416 [Abstract] [Full Text] [Related] Page: [Next] [New Search]